FDA warns of asenapine hypersensitivity

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2011年 / 1368卷 / 1期

关键词：

Public Health; Adverse Reaction; Therapeutic Intervention; Emergency Room; Allergic Reaction;

D O I：

10.2165/00128415-201113680-00004

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：2 / 2

相关论文

共 50 条

[11] FDA warns Pfizer on sertraline marketing
Barnett, AA
[J]. LANCET, 1996, 348 (9025): : 469 - 469
[12] FDA warns of seizure risk with dalfampridine
[J]. Reactions Weekly, 2012, 1412 (1) : 2 - 2
[13] FDA warns about heartburn drug
Josefson, D
[J]. BRITISH MEDICAL JOURNAL, 1998, 317 (7151): : 101 - 101
[14] PPIs linked to hypomagnesaemia warns FDA
[J]. Reactions Weekly, 2011, 1342 (1) : 2 - 2
[15] FDA Warns for Skin Sprayed With Evamist
不详
[J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (10) : 1306 - 1306
[16] FDA Warns of Risks of Body Sculpting
Rubin, Rita
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (03): : 201 - 201
[17] FDA warns Micotil 300 is dangerous
不详
[J]. AMERICAN JOURNAL OF VETERINARY RESEARCH, 2017, 78 (12) : 1355 - 1355
[18] FDA warns on DEHP in medical devices
不详
[J]. CHEMICAL & ENGINEERING NEWS, 2002, 80 (29) : 28 - 28
[19] FDA WARNS OF FAKE EBOLA DRUGS
不详
[J]. CHEMICAL & ENGINEERING NEWS, 2014, 92 (34) : 22 - 22
[20] FDA warns veterinarians about compounding
不详
[J]. JOURNAL OF EQUINE VETERINARY SCIENCE, 2004, 24 (05) : 184 - 184

← 1 2 3 4 5 →